"rofecoxib" meaning in English

See rofecoxib in All languages combined, or Wiktionary

Noun

IPA: /ˌɹoʊ.fəˈkɑk.sɪb/ [General-American]
Etymology: From rofe- (of unknown origin) + -coxib (“selective cyclo-oxygenase inhibitor”). Etymology templates: {{af|en|rofe-|-coxib|qq1=of unknown origin|t2=selective cyclo-oxygenase inhibitor}} rofe- (of unknown origin) + -coxib (“selective cyclo-oxygenase inhibitor”) Head templates: {{en-noun|-}} rofecoxib (uncountable)
  1. (pharmacology) A COX-2 inhibitor C₁₇H₁₄O₄S (trademark Vioxx) used to relieve the signs and symptoms of osteoarthritis and rheumatoid arthritis, to manage acute pain in adults, and to treat primary dysmenorrhea but withdrawn from sale by the manufacturer because of its link to cardiovascular events (as heart attack and stroke). Wikipedia link: rofecoxib Tags: uncountable Categories (topical): Pharmaceutical drugs

Download JSON data for rofecoxib meaning in English (2.4kB)

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "rofe-",
        "3": "-coxib",
        "qq1": "of unknown origin",
        "t2": "selective cyclo-oxygenase inhibitor"
      },
      "expansion": "rofe- (of unknown origin) + -coxib (“selective cyclo-oxygenase inhibitor”)",
      "name": "af"
    }
  ],
  "etymology_text": "From rofe- (of unknown origin) + -coxib (“selective cyclo-oxygenase inhibitor”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "rofecoxib (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with rofe-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -coxib",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "glosses": [
        "A COX-2 inhibitor C₁₇H₁₄O₄S (trademark Vioxx) used to relieve the signs and symptoms of osteoarthritis and rheumatoid arthritis, to manage acute pain in adults, and to treat primary dysmenorrhea but withdrawn from sale by the manufacturer because of its link to cardiovascular events (as heart attack and stroke)."
      ],
      "id": "en-rofecoxib-en-noun-v8zvV-OC",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "Vioxx",
          "Vioxx"
        ],
        [
          "osteoarthritis",
          "osteoarthritis"
        ],
        [
          "rheumatoid arthritis",
          "rheumatoid arthritis"
        ],
        [
          "pain",
          "pain"
        ],
        [
          "primary",
          "primary"
        ],
        [
          "dysmenorrhea",
          "dysmenorrhea"
        ],
        [
          "cardiovascular",
          "cardiovascular"
        ],
        [
          "heart attack",
          "heart attack"
        ],
        [
          "stroke",
          "stroke"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A COX-2 inhibitor C₁₇H₁₄O₄S (trademark Vioxx) used to relieve the signs and symptoms of osteoarthritis and rheumatoid arthritis, to manage acute pain in adults, and to treat primary dysmenorrhea but withdrawn from sale by the manufacturer because of its link to cardiovascular events (as heart attack and stroke)."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "rofecoxib"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌɹoʊ.fəˈkɑk.sɪb/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "rofecoxib"
}
{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "rofe-",
        "3": "-coxib",
        "qq1": "of unknown origin",
        "t2": "selective cyclo-oxygenase inhibitor"
      },
      "expansion": "rofe- (of unknown origin) + -coxib (“selective cyclo-oxygenase inhibitor”)",
      "name": "af"
    }
  ],
  "etymology_text": "From rofe- (of unknown origin) + -coxib (“selective cyclo-oxygenase inhibitor”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "rofecoxib (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English 4-syllable words",
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English terms prefixed with rofe-",
        "English terms suffixed with -coxib",
        "English terms with IPA pronunciation",
        "English uncountable nouns",
        "en:Pharmaceutical drugs"
      ],
      "glosses": [
        "A COX-2 inhibitor C₁₇H₁₄O₄S (trademark Vioxx) used to relieve the signs and symptoms of osteoarthritis and rheumatoid arthritis, to manage acute pain in adults, and to treat primary dysmenorrhea but withdrawn from sale by the manufacturer because of its link to cardiovascular events (as heart attack and stroke)."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "Vioxx",
          "Vioxx"
        ],
        [
          "osteoarthritis",
          "osteoarthritis"
        ],
        [
          "rheumatoid arthritis",
          "rheumatoid arthritis"
        ],
        [
          "pain",
          "pain"
        ],
        [
          "primary",
          "primary"
        ],
        [
          "dysmenorrhea",
          "dysmenorrhea"
        ],
        [
          "cardiovascular",
          "cardiovascular"
        ],
        [
          "heart attack",
          "heart attack"
        ],
        [
          "stroke",
          "stroke"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A COX-2 inhibitor C₁₇H₁₄O₄S (trademark Vioxx) used to relieve the signs and symptoms of osteoarthritis and rheumatoid arthritis, to manage acute pain in adults, and to treat primary dysmenorrhea but withdrawn from sale by the manufacturer because of its link to cardiovascular events (as heart attack and stroke)."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "rofecoxib"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌɹoʊ.fəˈkɑk.sɪb/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "rofecoxib"
}

This page is a part of the kaikki.org machine-readable English dictionary. This dictionary is based on structured data extracted on 2024-06-04 from the enwiktionary dump dated 2024-05-02 using wiktextract (e9e0a99 and db5a844). The data shown on this site has been post-processed and various details (e.g., extra categories) removed, some information disambiguated, and additional data merged from other sources. See the raw data download page for the unprocessed wiktextract data.

If you use this data in academic research, please cite Tatu Ylonen: Wiktextract: Wiktionary as Machine-Readable Structured Data, Proceedings of the 13th Conference on Language Resources and Evaluation (LREC), pp. 1317-1325, Marseille, 20-25 June 2022. Linking to the relevant page(s) under https://kaikki.org would also be greatly appreciated.